Key Segmentation
By Type
- Wearable
- Mobile Application
- Sensor
By Clinical Practice
- Diagnostic
- Monitoring
- Predictive
By Biomarker Category
- Neurophysiological
- Behavioral
By End Use
- Healthcare Companies
- Healthcare Providers
- Payers
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- ASEAN Countries
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Available Customization
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g. Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America held the largest share of the Psychiatric Digital Biomarkers Market in 2025, at approximately 58.40%.
The Psychiatric Digital Biomarkers Market was valued at USD 0.758 Billion in 2025.
Rising prevalence of mental health disorders combined with advancements in artificial intelligence and wearable technology is the major growth factor.
The Psychiatric Digital Biomarkers Market is expected to grow at a CAGR of 22.76% from 2026 to 2035.
The Wearable segment held approximately 39.90% share in 2025.
Get in Touch
